Clinical proteomics: translating benchside promise into bedside reality (Q34810370)

4 August 2017

1 reference

title

Clinical proteomics: translating benchside promise into bedside reality (English)

1 reference

4 August 2017

5

Lance A Liotta

1 reference

4 August 2017

Emanuel F Petricoin

1

1 reference

4 August 2017

Kathryn C Zoon

series ordinal

2

1 reference

4 August 2017

Elise C Kohn

series ordinal

3

1 reference

4 August 2017

J Carl Barrett

series ordinal

4

1 reference

4 August 2017

publication date

1 September 2002

1 reference

Nature Reviews Drug Discovery

4 August 2017

published in

1 reference

4 August 2017

volume

1

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

683-695

1 reference

Molecular profiling of human cancer

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Integrated genomic and proteomic analyses of a systematically perturbed metabolic network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

A network of protein-protein interactions in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

From the analysis of protein complexes to proteome-wide linkage maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Oncogenic kinase signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Protein modules and signalling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Recent developments in ovarian cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Screening for ovarian cancer: a pilot randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Proteomic approaches to biomarker discovery in prostate and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Osteopontin as a potential diagnostic biomarker for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

The relationship between the mass spectra of drugs and their biological activity—An application of artificial intelligence to chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Metabonomics: a platform for studying drug toxicity and gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Myocardial SPET: artificial neural networks describe extent and severity of perfusion defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Neural network assessment of perioperative cardiac risk in vascular surgery patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Self-Organized Formation of Topologically Correct Feature Maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

An approach to proteomic analysis of human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

New approaches to proteomic analysis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Proteomic profiling of the cancer microenvironment by antibody arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Automatic identification of proteins with a MALDI-quadrupole ion trap mass spectrometer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Analysis of quantitative proteomic data generated via multidimensional protein identification technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Quantitative proteome analysis by solid-phase isotope tagging and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

High-throughput protein arrays: prospects for molecular diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Tissue microarrays for rapid linking of molecular changes to clinical endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Cancer gene therapy: hard lessons and new courses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Enzyme-targeted, nucleoside-based radiopharmaceuticals for scintigraphic monitoring of gene transfer and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Targeted therapy for malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Cell surface receptor-targeted therapy of acute myeloid leukemia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Recent advances in immunotherapy and monoclonal antibody treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Molecular addresses in blood vessels as targets for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Proliferation, cell cycle and apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Her-2/neu and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Trastuzumab: hopes and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

The role of mitogen-activated protein (MAP) kinase in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Tyrosine kinase inhibitors: from rational design to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Receptor tyrosine kinases as targets for anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

High-Throughput Proteomics Using High-Efficiency Multiple-Capillary Liquid Chromatography with On-Line High-Performance ESI FTICR Mass Spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Proteomic analysis of human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Proteomics comes to the surface

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Clinical proteomics: personalized molecular medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

Development of anticancer drugs targeting the MAP kinase pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRD891

31 March 2020

Identifiers

DOI

10.1038/NRD891

1 reference

Dimensions Publication ID

4 August 2017

1004955629

0 references

1 reference